Biblio
Export 1382 results:
Author Title [ Type
Filters: First Letter Of Last Name is G [Clear All Filters]
“Depressive Symptoms Are Associated with Cognitive Function in the Elderly with Type 2 Diabetes.”, J Alzheimers Dis, vol. 65, no. 2, pp. 683-692, 2018.
, “Depressive Symptoms Imputed Across the Life Course Are Associated with Cognitive Impairment and Cognitive Decline.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1379-1389, 2021.
, “Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial.”, J Alzheimers Dis, vol. 62, no. 2, pp. 649-663, 2018.
, “Detecting Anosognosia from the Prodromal Stage of Alzheimer's Disease.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1723-1733, 2023.
, “Detecting At-Risk Alzheimer's Disease Cases.”, J Alzheimers Dis, vol. 60, no. 1, pp. 97-105, 2017.
, “Detecting At-Risk Alzheimer's Disease Cases.”, J Alzheimers Dis, vol. 60, no. 1, pp. 97-105, 2017.
, “Detection of Dementia Cases in Two Swedish Health Registers: A Validation Study.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1301-1310, 2018.
, “Detection of Mild Cognitive Impairment in an At-Risk Group of Older Adults: Can a Novel Self-Administered Serious Game-Based Screening Test Improve Diagnostic Accuracy?”, J Alzheimers Dis, vol. 78, no. 1, pp. 405-412, 2020.
, “Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1259-1272, 2016.
, “Development and Validation of a High Sensitivity Assay for Measuring p217 + tau in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1417-1430, 2020.
, “Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 52, no. 1, pp. 17-24, 2016.
, “Development of Classification Models for the Prediction of Alzheimer's Disease Utilizing Circulating Sex Hormone Ratios.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1029-1046, 2020.
, “Diabetes and Alzheimer's Disease: Can Tea Phytochemicals Play a Role in Prevention?”, J Alzheimers Dis, vol. 59, no. 2, pp. 481-501, 2017.
, “Diabetes is Associated with Worse Executive Function in Both Eastern and Western Populations: Shanghai Aging Study and Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 47, no. 1, pp. 167-76, 2015.
, “Diabetes is Not Associated with Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1035-1043, 2017.
, “Diabetic Retinopathy Predicts Risk of Alzheimer's Disease: A Danish Registry-Based Nationwide Cohort Study.”, J Alzheimers Dis, vol. 86, no. 1, pp. 451-460, 2022.
, “Diagnosing Mild Cognitive Impairment Among Racially Diverse Older Adults: Comparison of Consensus, Actuarial, and Statistical Methods.”, J Alzheimers Dis, vol. 85, no. 2, pp. 627-644, 2021.
, “Diagnosis of Dementia in the Specialist Setting: A Comparison Between the Swedish Dementia Registry (SveDem) and the Registry of Dementias of Girona (ReDeGi).”, J Alzheimers Dis, vol. 53, no. 4, pp. 1341-51, 2016.
, “Diagnosis of Dementia in the Specialist Setting: A Comparison Between the Swedish Dementia Registry (SveDem) and the Registry of Dementias of Girona (ReDeGi).”, J Alzheimers Dis, vol. 53, no. 4, pp. 1341-51, 2016.
, “The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.”, Alzheimers Dement, vol. 7, no. 3, pp. 270-9, 2011.
, “Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1287-97, 2016.
, “Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.”, J Alzheimers Dis, vol. 58, no. 2, pp. 355-359, 2017.
, “Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.”, J Alzheimers Dis, vol. 58, no. 2, pp. 355-359, 2017.
, “Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 97-106, 2016.
, “Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 97-106, 2016.
,